Company page

Verici Dx Plc

Verici Dx Plc is a public company listed on the UK market under the ticker VRCI, with a market capitalization of approximately £10.73 million. The company focuses on developing innovative diagnostic solutions for organ transplant patients. Verici Dx aims to improve patient outcomes through its advanced technology and research initiatives.